- Home
- ATHE vs ADN Comparison
ATHE vs ADN Comparison
Compare ATHE & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHE
- ADN
- Stock Information
- Founded
- ATHE 1997
- ADN 2006
- Country
- ATHE Australia
- ADN United States
- Employees
- ATHE N/A
- ADN N/A
- Industry
- ATHE Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- ATHE Health Care
- ADN Utilities
- Exchange
- ATHE Nasdaq
- ADN Nasdaq
- Market Cap
- ATHE 10.1M
- ADN 8.5M
- IPO Year
- ATHE N/A
- ADN N/A
- Fundamental
- Price
- ATHE $1.07
- ADN $7.30
- Analyst Decision
- ATHE Buy
- ADN
- Analyst Count
- ATHE 1
- ADN 0
- Target Price
- ATHE $4.00
- ADN N/A
- AVG Volume (30 Days)
- ATHE 13.7K
- ADN 3.7M
- Earning Date
- ATHE 12-03-2024
- ADN 10-15-2024
- Dividend Yield
- ATHE N/A
- ADN N/A
- EPS Growth
- ATHE N/A
- ADN N/A
- EPS
- ATHE N/A
- ADN N/A
- Revenue
- ATHE $2,681,669.00
- ADN $7,026,000.00
- Revenue This Year
- ATHE N/A
- ADN $2,232.99
- Revenue Next Year
- ATHE N/A
- ADN $91.56
- P/E Ratio
- ATHE N/A
- ADN N/A
- Revenue Growth
- ATHE 2.63
- ADN 9.01
- 52 Week Low
- ATHE $1.00
- ADN $1.71
- 52 Week High
- ATHE $5.41
- ADN $15.66
- Technical
- Relative Strength Index (RSI)
- ATHE 37.45
- ADN 70.71
- Support Level
- ATHE $1.05
- ADN $4.87
- Resistance Level
- ATHE $1.13
- ADN $7.91
- Average True Range (ATR)
- ATHE 0.07
- ADN 1.27
- MACD
- ATHE -0.01
- ADN 0.23
- Stochastic Oscillator
- ATHE 23.88
- ADN 73.81
About ATHE Alterity Therapeutics Limited
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.